Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.

Furlanetto TW, Faulhaber GA.

Arch Intern Med. 2011 Aug 8;171(15):1391-2. doi: 10.1001/archinternmed.2011.199. Epub 2011 May 9.

PMID:
21555654
2.

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.

Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS.

CMAJ. 2011 Feb 22;183(3):310-9. doi: 10.1503/cmaj.092129. Epub 2010 Dec 20. Review.

3.

Gastric secretion.

Schubert ML.

Curr Opin Gastroenterol. 2010 Nov;26(6):598-603. doi: 10.1097/MOG.0b013e32833f2010. Review.

PMID:
20838342
4.

Safety of proton pump inhibitor exposure.

Yang YX, Metz DC.

Gastroenterology. 2010 Oct;139(4):1115-27. doi: 10.1053/j.gastro.2010.08.023. Epub 2010 Aug 19. Review.

PMID:
20727892
5.

Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Dublin S, Walker RL, Jackson ML, Nelson JC, Weiss NS, Jackson LA.

Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):792-802. doi: 10.1002/pds.1978.

6.

Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.

Johnstone J, Nerenberg K, Loeb M.

Aliment Pharmacol Ther. 2010 Jun;31(11):1165-77. doi: 10.1111/j.1365-2036.2010.04284.x. Epub 2010 Mar 4.

7.

A case series of proton pump inhibitor-induced hypomagnesemia.

Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zietse R.

Am J Kidney Dis. 2010 Jul;56(1):112-6. doi: 10.1053/j.ajkd.2009.11.019. Epub 2010 Feb 26.

PMID:
20189276
8.

Acid-suppressive drugs and community-acquired pneumonia.

Rodríguez LA, Ruigómez A, Wallander MA, Johansson S.

Epidemiology. 2009 Nov;20(6):800-6. doi: 10.1097/EDE.0b013e3181b5f27d.

PMID:
19797970
9.

Insights into the future of gastric acid suppression.

DeVault KR, Talley NJ.

Nat Rev Gastroenterol Hepatol. 2009 Sep;6(9):524-32. doi: 10.1038/nrgastro.2009.125. Review.

PMID:
19713987
10.

Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.

Fournier MR, Targownik LE, Leslie WD.

Maturitas. 2009 Sep 20;64(1):9-13. doi: 10.1016/j.maturitas.2009.07.006. Epub 2009 Aug 11. Review.

PMID:
19674854
11.

Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

Herzig SJ, Howell MD, Ngo LH, Marcantonio ER.

JAMA. 2009 May 27;301(20):2120-8. doi: 10.1001/jama.2009.722.

PMID:
19470989
12.

Proton pump inhibitors: actions and reactions.

Mullin JM, Gabello M, Murray LJ, Farrell CP, Bellows J, Wolov KR, Kearney KR, Rudolph D, Thornton JJ.

Drug Discov Today. 2009 Jul;14(13-14):647-60. doi: 10.1016/j.drudis.2009.03.014. Epub 2009 Apr 8. Review.

PMID:
19443264
13.

Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients.

Miano TA, Reichert MG, Houle TT, MacGregor DA, Kincaid EH, Bowton DL.

Chest. 2009 Aug;136(2):440-447. doi: 10.1378/chest.08-1634. Epub 2009 Mar 24.

PMID:
19318661
14.

Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.

Myles PR, Hubbard RB, McKeever TM, Pogson Z, Smith CJ, Gibson JE.

Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):269-75. doi: 10.1002/pds.1715.

PMID:
19235776
15.

Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia.

Roughead EE, Ramsay EN, Pratt NL, Ryan P, Gilbert AL.

Med J Aust. 2009 Feb 2;190(3):114-6.

PMID:
19203305
16.

Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.

Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ.

Aliment Pharmacol Ther. 2009 Mar 15;29(6):626-34. doi: 10.1111/j.1365-2036.2008.03924.x. Epub 2008 Dec 19.

17.

The effect of proton pump inhibitors on the human microbiota.

Vesper BJ, Jawdi A, Altman KW, Haines GK 3rd, Tao L, Radosevich JA.

Curr Drug Metab. 2009 Jan;10(1):84-9. Review.

PMID:
19149516
18.

Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit?

Beaulieu M, Williamson D, Sirois C, Lachaine J.

J Crit Care. 2008 Dec;23(4):513-8. doi: 10.1016/j.jcrc.2007.11.003.

PMID:
19056015
19.

Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.

Savarino V, Di Mario F, Scarpignato C.

Pharmacol Res. 2009 Mar;59(3):135-53. doi: 10.1016/j.phrs.2008.09.016. Epub 2008 Oct 8. Review.

PMID:
18977444
20.

Proton pump inhibitors are an independent risk factor for an increased length of hospital stay in patients with Clostridium difficile infection.

Nachnani JS, Bulchandani D, Allen MJ.

Indian J Gastroenterol. 2008 Jul-Aug;27(4):171-2. No abstract available.

PMID:
18974472

Supplemental Content

Support Center